NR4A1 and acute myeloid leukemia: LXR agonists were inefficient at inducing death and autophagy in AML cells (Fig. 6k, l; Supplementary Fig. 6s) and led to only a weak expression of Nur77 and NOR1 relative to DDA treatment (Supplementary Fig. 6t).